Skip to main content
. 2015 Nov 19;2015(11):CD003357. doi: 10.1002/14651858.CD003357.pub4

Elzeiny 2014.

Methods Randomised controlled parallel trial
Participants 44 couples
Inclusion criteria
Adults who had primary or secondary infertility ≥ 1 year in duration with evidence of ovulation and tubal patency, aged 18 to 42 years for females and 18 to 60 years for males
Exclusion criteria
IUI or IVF treatment in the previous 12 months, coital disorder, untreated ovulatory disorders or endometriosis (American Fertility Society criteria grades 2 to 4), tubal obstruction, abnormal semen analyses (concentration < 20 × 106/mL, progressive motility < 25%, abnormal morphology > 95% or positive sperm antibodies) or any contraindication for multiple pregnancy
Interventions IVF vs IUI
Outcomes Live birth rate, clinical pregnancy rate, multiple pregnancy rate, OHSS, cost per live birth
Notes Financial support provided by a pharmaceutical company
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "computer‐generated, adaptive‐biased coin randomisation schedule"
Allocation concealment (selection bias) Low risk "sequentially numbered opaque sealed envelopes"
Blinding (performance bias and detection bias) 
 All outcomes Unclear risk This was not mentioned
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 43/44 randomly assigned women were included in the analysis
Selective reporting (reporting bias) Low risk Study reported primary and secondary treatment outcomes adequately including adverse outcomes
Other bias Low risk No other potential bias could be observed